More than half of the topical antifungal prescriptions in the United States in 2023 may have been unnecessary, and only 16% of patients received diagnostic testing to confirm the need for these ...

Recce Pharmaceuticals’ synthetic gel successfully treated a range of skin infections in a phase 2 trial, leading the ...